GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (AMEX:CVM) » Definitions » Cyclically Adjusted Book per Share

CEL-SCI (CEL-SCI) Cyclically Adjusted Book per Share : $0.71 (As of Mar. 2024)


View and export this data going back to 1991. Start your Free Trial

What is CEL-SCI Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

CEL-SCI's adjusted book value per share for the three months ended in Mar. 2024 was $0.264. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.71 for the trailing ten years ended in Mar. 2024.

During the past 12 months, CEL-SCI's average Cyclically Adjusted Book Growth Rate was -48.20% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -37.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of CEL-SCI was 12.40% per year. The lowest was -40.00% per year. And the median was -15.90% per year.

As of today (2024-06-08), CEL-SCI's current stock price is $1.30. CEL-SCI's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $0.71. CEL-SCI's Cyclically Adjusted PB Ratio of today is 1.83.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CEL-SCI was 3.78. The lowest was 0.05. And the median was 0.48.


CEL-SCI Cyclically Adjusted Book per Share Historical Data

The historical data trend for CEL-SCI's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CEL-SCI Cyclically Adjusted Book per Share Chart

CEL-SCI Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.98 4.23 2.61 1.94 1.02

CEL-SCI Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.37 1.18 1.02 0.80 0.71

Competitive Comparison of CEL-SCI's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, CEL-SCI's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CEL-SCI's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CEL-SCI's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where CEL-SCI's Cyclically Adjusted PB Ratio falls into.



CEL-SCI Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CEL-SCI's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.264/131.7762*131.7762
=0.264

Current CPI (Mar. 2024) = 131.7762.

CEL-SCI Quarterly Data

Book Value per Share CPI Adj_Book
201406 5.692 100.560 7.459
201409 3.188 100.428 4.183
201412 3.235 99.070 4.303
201503 0.094 99.621 0.124
201506 0.876 100.684 1.147
201509 -1.060 100.392 -1.391
201512 0.679 99.792 0.897
201603 -0.545 100.470 -0.715
201606 -0.650 101.688 -0.842
201609 -0.109 101.861 -0.141
201612 0.581 101.863 0.752
201703 -0.355 102.862 -0.455
201706 0.010 103.349 0.013
201709 -0.280 104.136 -0.354
201712 -0.365 104.011 -0.462
201803 -0.184 105.290 -0.230
201806 -0.064 106.317 -0.079
201809 0.000 106.507 0.000
201812 0.097 105.998 0.121
201903 0.032 107.251 0.039
201906 0.034 108.070 0.041
201909 0.146 108.329 0.178
201912 0.194 108.420 0.236
202003 0.327 108.902 0.396
202006 0.494 108.767 0.599
202009 0.509 109.815 0.611
202012 0.725 109.897 0.869
202103 0.718 111.754 0.847
202106 1.392 114.631 1.600
202109 1.308 115.734 1.489
202112 1.187 117.630 1.330
202203 1.042 121.301 1.132
202206 0.893 125.017 0.941
202209 0.740 125.227 0.779
202212 0.608 125.222 0.640
202303 0.460 127.348 0.476
202306 0.330 128.729 0.338
202309 0.279 129.860 0.283
202312 0.253 129.419 0.258
202403 0.264 131.776 0.264

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


CEL-SCI  (AMEX:CVM) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

CEL-SCI's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=1.30/0.71
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of CEL-SCI was 3.78. The lowest was 0.05. And the median was 0.48.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


CEL-SCI Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of CEL-SCI's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


CEL-SCI (CEL-SCI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CEL-SCI Corp (AMEX:CVM) » Definitions » Cyclically Adjusted Book per Share
Traded in Other Exchanges
Address
8229 Boone Boulevard, Suite 802, Vienna, VA, USA, 22182
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
Executives
Gail K Naughton director C. R. BARD, INC., 730 CENTRAL AVENUE, MURRAY HILL NJ 07974
Peter R Young director 8229 BOONE BLVD, STE 802, VIENNA VA 22182
John Cipriano officer: Senior Vice President 8229 BOONE BLVD, SUITE 802, VIENNA VA 22182
Robert Eugene Watson director 245 N. HIGHLAND AVE NE, SUITE 230-296, ATLANTA GA 30307
Bruno Jean-marie Baillavoine director 8229 BOONE BLVD., SUITE 802, VIENNA VA 22182
Eyal Talor officer: Chief Scientific Officer 8229 BOONE BLVD, STE 802, VIENNA VA 22182
Geert R Kersten director, officer: Chief Executive Officer 8229 BOONE BLVD, STE 802, VIENNA VA 22182
Daniel H Zimmerman officer: Sr. Vice President, Research 8229 BOONE BLVD, STE 802, VIENNA VA 22182
Patricia B Prichep officer: Sr. Vice President, Operations 8229 BOONE BLVD., SUITE 802, VIENNA VA 22182
Clara Maximilian De director, officer: President
C Richard Kinsolving director 8229 BOONE BLVD, STE 802, VIENNA VA 22182
Alexander G Esterhazy director 8229 BOONE BLVD, STE 802, VIENNA VA 22182